The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer.
The mammalian target of rapamycin (mTOR) is a highly conserved kinase that belongs to the phosphoinositide 3-kinase-related protein kinases (PIKK) family. mTOR participates in two distinct complexes, ...
Cytotoxic T lymphocytes play a crucial role in adaptive immunity, primarily defending against tumors and viruses. These cells develop within the thymus gland and undergo rapid activation upon ...
News Medical on MSN
Dresden study uncovers new key mechanism in cancer cells
A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides ...
8don MSN
Some mammals can hit pause on a pregnancy—understanding how that happens could help us treat cancer
Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...
Angelini Pharma has licensed a preclinical-stage mTOR inhibitor from South Korean biotech Sovargen with potential for genetic forms of epilepsy and other brain disorders. The $550 million-plus deal ...
Oncotelic Therapeutics Inc. 's (OTCQB: OTLC) Sapu Nano joint venture is making progress with Sapu003, its intravenous Deciparticle formulation of everolimus, the powerful drug to fight cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback